Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma-Reference-Cited by-同舟云学术

Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma

Published:2020-08-04 Issue:35 Volume:39 Page:5782-5794
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Totani Haruhito,Shinjo Keiko,Suzuki Miho,Katsushima Keisuke^ORCID,Mase Shoko,Masaki Ayako,Ito Asahi,Ri Masaki^ORCID,Kusumoto Shigeru,Komatsu Hirokazu,Ishida Takashi,Inagaki Hiroshi,Iida Shinsuke,Kondo Yutaka^ORCID

Funder

MEXT | Japan Society for the Promotion of Science

Research Grant of the Princess Takamatsu Cancer Research Fund

National Cancer Center Research and Development Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-020-01393-x.pdf

Reference38 articles.

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.

2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415–9.

3. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78:6476–80.

4. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol. 1991;79:428–37.

5. Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126:2570–7.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including hepatocyte growth factor;Biomedicine & Pharmacotherapy;2024-08

2. KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination;Cell Communication and Signaling;2024-06-12

3. T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including Hepatocyte Growth factor;2024-04-26

4. Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer;Cellular and Molecular Life Sciences;2024-01-12

5. Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options;International Immunopharmacology;2023-08